The development of NLRP3 -/- x APP/PS1 transgenic rodent models demonstrates that by reducing inflammation in AD models, histopathology hallmarks and cognitive decline can be mitigated [36]. The gene discussed is NLRP3; the disease is Alzheimer disease.